Havrix should not be administered to subjects with known hypersensitivity to any component of the vaccine (see Description), or to subjects having shown signs of hypersensitivity after previous administration of Havrix.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
